Menu
Recruiting NCT07027891

The Rule-Out Acute Myocardial Infarction Using Aritifical Intelligence Electrocardiogram (ROMIAE) 2 Trial

No phase Interventional Myocardial Infarction (MI) Chest Pain Rule Out Myocardial Infarction

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: AI-ECG.
Who it may be relevant to
Registry conditions: Myocardial Infarction (MI), Chest Pain Rule Out Myocardial Infarction. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
South Korea
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

ROMIAE 2 Trial: Randomized Controlled Trial for Managing Suspicious Acute Myocardial Infarction in ED Using AI-ECG

Overview

This study is to see whether the AI ECG assisted protocol is as safe and efficacious as conventional protocol in early triage of suspected myocardial infarction.

Interventions

  • Device AI-ECG
    The patients in AI-ECG group would be managed with the information of the myocardial infarction risk score in AI-ECG in addition to the usual care.

Primary outcome measures

  • 30 Days MACE(Major adverse cardiac events) [Time frame: 30 days]
Secondary outcome measures (12)
  • Missed acute myocardial infarction at index visit [Time frame: 30 days]
  • AI-ECG 30 days MACE prediction performance [Time frame: 30 days]
  • AI-ECG 30 days MACE prediction performance [Time frame: 30 Days]
  • AI-ECG 30 days MACE prediction performance [Time frame: 30 Days]
  • AI-ECG acute myocardial infarction (index visit) discrimination performance [Time frame: 30 days]
  • AI-ECG acute myocardial infarction (index visit) discrimination performance [Time frame: 30 Days]
  • AI-ECG acute myocardial infarction (index visit) discrimination performance [Time frame: 30 Days]
  • Medical resources utilization [Time frame: 30 days]
  • Medical resources utilization [Time frame: 24 hours]
  • Medical resources utilization [Time frame: 7 Days]
  • Medical resources utilization [Time frame: 30 days]
  • Medical resources utilization [Time frame: 30 days]

Eligibility criteria

Inclusion criteria

  • chest pain
  • suspicious of acute myocardial infarction

Exclusion criteria

  • STEMI
  • Revisit of same symptoms within 1 week
  • traumatic chest pain
  • Pneumothorax
  • Transferred from other hospital diagnosed of AMI
  • Cardiac arrest
  • Chest pain of clearly non-cardiac etiology
  • declined to participate in the study

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Diagnostic

Study locations

South Korea · 12 centers
  • Asan Medical Center — Seoul
  • CHA Bundang Medical Center — Seoul
  • Ewha Womans University — Seoul
  • Gangnam Severance Hospital — Seoul
  • Hanyang University — Seoul
  • Jeonbuk National University Hospital — Seoul
  • Korea University Ansan Hospital — Seoul
  • Korea University Guro Hospital — Seoul
  • … and 4 more centers

Identifiers

NCT: NCT07027891 · ROMIAE II trial · RS-2025-02213791

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗